Inventor

MUELLER STEPHAN GEORG

US57 patents

⚠️ This page may combine multiple inventors who share the name “MUELLER STEPHAN GEORG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MUELLER STEPHAN GEORG

BOEHRINGER INGELHEIM INT

Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

CGRP antagonists

Amide compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

β-ketoamide compounds with MCH antagonistic activity

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

CREE INC

One hundred millimeter high purity semi-insulating single crystal silicon carbide wafer

One hundred millimeter single crystal silicon carbide wafer

Seeded single crystal silicon carbide growth and resulting crystals

Minimizing degradation of SiC bipolar semiconductor devices

Reduction of subsurface damage in the production of bulk SiC crystals

Minimizing degradation of SiC bipolar semiconductor devices

Minimizing degradation of SiC bipolar semiconductor devices

BOEHRINGER INGELHEIM PHARMA

Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds

Beta-agonists, processes for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Substituted piperidines, medicaments containing these compounds, and methods for the production thereof

CENTREXION THERAPEUTICS CORP

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

GOTTSCHLING DIRK

Compounds

Pyrimidine derivatives which are CGRP—antagonists

CGRP antagonists

STENKAMP DIRK

Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

JENNY JASON RONALD

One hundred millimeter single crystal silicon carbide wafer

NOVO NORDISK AS

Substituted imidazoles, their preparation and use

RIETHER DORIS

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

HEIMANN ANNEKATRIN

Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors